GlobalData on MSN1mon
Natera reports new data from Phase III study of colorectal cancer detection test
The trial utilised Signatera to determine the benefits of adding celecoxib to the standard of care adjuvant chemotherapy with ...
Nature2mon
Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer
Rothenberg et al. 1 sought to demonstrate the noninferiority of XELOX to FOLFOX-4 as second-line therapy in patients with progressive disease during or shortly after first-line therapy with ...